Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Zentalis Pharmaceuticals Inc. > Hedge Fund Holdings

Zentalis Pharmaceuticals Inc. (ZNTL)

Market is closed
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last update:
  • Displaying 1
No. Hedge Fund Shares Value Activity % Port
1.
Tybourne Capital Management

Eashwar Krishnan

 1,478,152 $1,714,656 +54% 4.96%
Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)